LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

LLY

1,021.76

-0.21%↓

JNJ

199.29

+1.67%↑

ABBV

233.81

+0.62%↑

UNH

320.41

-0.3%↓

AZN

89.34

+0.22%↑

Search

Certara Inc

Cerrado

SectorSanidad

8.14 -2.16

Resumen

Variación precio

24h

Actual

Mínimo

8.09

Máximo

8.3

Métricas clave

By Trading Economics

Ingresos

3.5M

1.5M

Ventas

46K

105M

P/B

Media del Sector

123.143

105.69

BPA

0.14

Margen de beneficios

1.458

Empleados

1,487

EBITDA

-21M

8.7M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+64.59% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-506M

1.4B

Apertura anterior

10.3

Cierre anterior

8.14

Noticias sobre sentimiento de mercado

By Acuity

94%

6%

358 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

Certara Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

17 nov 2025, 18:59 UTC

Principales Movimientos del Mercado

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

17 nov 2025, 23:40 UTC

Charlas de Mercado

Gold Consolidates Amid Mixed Signals -- Market Talk

17 nov 2025, 23:34 UTC

Charlas de Mercado

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

17 nov 2025, 22:58 UTC

Charlas de Mercado

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

17 nov 2025, 22:46 UTC

Charlas de Mercado

Risk Assets Set to Have a Strong 2026 -- Market Talk

17 nov 2025, 22:06 UTC

Adquisiciones, fusiones, absorciones

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

17 nov 2025, 22:02 UTC

Ganancias

Trip.com Group 3Q Rev $2.6B >TCOM

17 nov 2025, 22:02 UTC

Ganancias

Trip.com Group 3Q Adj EPS $3.87 >TCOM

17 nov 2025, 22:02 UTC

Ganancias

Trip.com Group 3Q EPS $4.02 >TCOM

17 nov 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

17 nov 2025, 21:40 UTC

Ganancias

James Hardie Industries 2Q Adj EPS 26c >JHX

17 nov 2025, 21:40 UTC

Ganancias

James Hardie Industries 2Q Loss/Shr 10c >JHX

17 nov 2025, 21:39 UTC

Ganancias

James Hardie Industries 2Q Sales $1.29B >JHX

17 nov 2025, 21:38 UTC

Ganancias
Adquisiciones, fusiones, absorciones

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 nov 2025, 21:38 UTC

Ganancias

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

17 nov 2025, 21:10 UTC

Ganancias

XP Inc. 3Q EPS BRL2.47 >XP

17 nov 2025, 21:10 UTC

Ganancias

XP Inc. 3Q Rev BRL4.67B >XP

17 nov 2025, 20:20 UTC

Charlas de Mercado

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

17 nov 2025, 20:12 UTC

Charlas de Mercado

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

17 nov 2025, 20:12 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 nov 2025, 20:09 UTC

Charlas de Mercado

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

17 nov 2025, 19:29 UTC

Charlas de Mercado

Gold Slide Continues to Start Week -- Market Talk

17 nov 2025, 19:16 UTC

Ganancias
Adquisiciones, fusiones, absorciones

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 nov 2025, 18:20 UTC

Adquisiciones, fusiones, absorciones

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

17 nov 2025, 16:45 UTC

Adquisiciones, fusiones, absorciones

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

17 nov 2025, 16:16 UTC

Ganancias
Adquisiciones, fusiones, absorciones

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

17 nov 2025, 16:15 UTC

Ganancias

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

17 nov 2025, 15:40 UTC

Adquisiciones, fusiones, absorciones

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

17 nov 2025, 15:22 UTC

Adquisiciones, fusiones, absorciones

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

17 nov 2025, 15:19 UTC

Charlas de Mercado

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

Comparación entre iguales

Cambio de precio

Certara Inc previsión

Precio Objetivo

By TipRanks

64.59% repunte

Estimación a 12 Meses

Media 13.71 USD  64.59%

Máximo 16 USD

Mínimo 9 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Certara Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

9 ratings

4

Comprar

5

Mantener

0

Vender

Puntuación técnica

By Trading Central

11.27 / 12.79Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Very Strong Bullish Evidence

Largo Plazo

Strong Bullish Evidence

Sentimiento

By Acuity

358 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
help-icon Live chat